GlassScriptPhysician profile
Dwayne Dunbar
NPI 1932636750
$1,626.09
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $533 · 2023: $480 · 2024: $614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,093.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $843.27 | 2022-2024 | Intellis Adaptivestim, Synchromedii, V-Loc 180 |
| Nevro Corp. | $232.35 | 2022-2023 | Senza |
| Collegium Pharmaceutical, INC. | $161.40 | 2024 | Belbuca, Xtampza |
| Saluda Medical Americas, INC. | $144.23 | 2024 | Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.05 | 2024 | Relistor |
| Boston Scientific Corporation | $45.72 | 2024 | Wavewriter Alpha Prime 16 |
| Lundbeck LLC | $31.64 | 2024 | Vyepti |
| Stryker Corporation | $29.58 | 2023 | Spinejack |
| Avanos Medical | $24.40 | 2023 | Coolief* Cooled Radiofrequency |
| Pfizer INC. | $22.67 | 2024 | |
| Ibsa Pharma INC. | $15.27 | 2024 | Tirosint, Licart |
| Painteq LLC | $14.00 | 2024 | Painteq |
| Ossur Americas, INC. | $13.51 | 2024 | Miami J |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwayne Dunbar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.